|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0024623,
umls-concept:C0034656,
umls-concept:C0051571,
umls-concept:C0205195,
umls-concept:C0282461,
umls-concept:C0543467,
umls-concept:C0936012,
umls-concept:C1257890,
umls-concept:C1516985,
umls-concept:C1521996,
umls-concept:C1522673,
umls-concept:C1707455
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-1-23
|
|
pubmed:abstractText |
In patients who underwent radical resection for gastric cancer, we investigate the relative efficacy of combined 5-fluorouracil+adriamycin or epirubicin and methotrexate with leucovorin rescue (FAMTX or FEMTX) compared with a control arm.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BaronBB,
pubmed-author:BlissJ MJM,
pubmed-author:CoombesR CRC,
pubmed-author:CouvreurM LML,
pubmed-author:CrivellariDD,
pubmed-author:Dos SantosJ GuimaraesJG,
pubmed-author:EORTC GI Group,
pubmed-author:EmsonMM,
pubmed-author:FountzilasGG,
pubmed-author:HallEE,
pubmed-author:HomewoodJJ,
pubmed-author:ICCE,
pubmed-author:LiseMM,
pubmed-author:MarchetAA,
pubmed-author:NittsRR,
pubmed-author:SanchezEE,
pubmed-author:SavaCC,
pubmed-author:TresAA,
pubmed-author:Van CutsemEE,
pubmed-author:WilkBB,
pubmed-author:WoodsEE,
pubmed-author:YonemitsuHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
262-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16293676-Adenocarcinoma,
pubmed-meshheading:16293676-Adult,
pubmed-meshheading:16293676-Aged,
pubmed-meshheading:16293676-Antineoplastic Agents,
pubmed-meshheading:16293676-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16293676-Chemotherapy, Adjuvant,
pubmed-meshheading:16293676-Clinical Trials, Phase III as Topic,
pubmed-meshheading:16293676-Combined Modality Therapy,
pubmed-meshheading:16293676-Disease-Free Survival,
pubmed-meshheading:16293676-Doxorubicin,
pubmed-meshheading:16293676-Epirubicin,
pubmed-meshheading:16293676-Female,
pubmed-meshheading:16293676-Fluorouracil,
pubmed-meshheading:16293676-Humans,
pubmed-meshheading:16293676-Male,
pubmed-meshheading:16293676-Methotrexate,
pubmed-meshheading:16293676-Middle Aged,
pubmed-meshheading:16293676-Randomized Controlled Trials as Topic,
pubmed-meshheading:16293676-Stomach Neoplasms,
pubmed-meshheading:16293676-Survival Analysis
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.
|
|
pubmed:affiliation |
Università di Padova, Clinica Chirurgica II, Padova, Italy, and Laurentius Hospital, Roermond, The Netherlands. donato.nitti@unipd.it
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Meta-Analysis,
Research Support, N.I.H., Extramural
|
